Quarterly report pursuant to Section 13 or 15(d)

Statements of Changes in Stockholders' Equity (Unaudited)

v3.20.2
Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2018 $ 42,578 $ 57,868,593 $ (39,948,553) $ 17,962,618
Beginning balance, shares at Dec. 31, 2018 42,578,208      
Stock based compensation 763,659 763,659
Exercise of employee stock options $ 95 151,506 151,601
Exercise of employee stock options, shares 94,530      
Exercise of warrants $ 50 57,450 57,500
Exercise of warrants, shares 50,000      
Net loss     (2,920,584) (2,920,584)
Ending balance at Mar. 31, 2019 $ 42,723 58,841,208 (42,869,137) 16,014,794
Beginning balance, shares at Mar. 31, 2019 42,722,738      
Beginning balance at Dec. 31, 2018 $ 42,578 57,868,593 (39,948,553) 17,962,618
Beginning balance, shares at Dec. 31, 2018 42,578,208      
Equity modification expense      
Net loss       (9,328,053)
Ending balance at Sep. 30, 2019 $ 42,861 60,211,715 (49,276,606) 10,977,970
Beginning balance, shares at Sep. 30, 2019 42,861,422      
Beginning balance at Mar. 31, 2019 $ 42,723 58,841,208 (42,869,137) 16,014,794
Beginning balance, shares at Mar. 31, 2019 42,722,738      
Stock based compensation 664,164 664,164
Exercise of employee stock options $ 138 121,833 121,971
Exercise of employee stock options, shares 138,684      
Net loss     (3,058,042) (3,058,042)
Ending balance at Jun. 30, 2019 $ 42,861 59,627,205 (45,927,179) 13,742,887
Beginning balance, shares at Jun. 30, 2019 42,861,422      
Equity modification expense      
Net loss     (3,349,427) (3,349,427)
Ending balance at Sep. 30, 2019 $ 42,861 60,211,715 (49,276,606) 10,977,970
Beginning balance, shares at Sep. 30, 2019 42,861,422      
Beginning balance at Dec. 31, 2019 $ 43,069 61,087,082 (52,993,325) 8,136,826
Beginning balance, shares at Dec. 31, 2019 43,069,418      
Stock based compensation 882,645 882,645
Equity modification expense 802,400 802,400
Exercise of employee stock options $ 72 42,154 42,226
Exercise of employee stock options, shares 71,981      
Net loss (4,217,563) (4,217,563)
Ending balance at Mar. 31, 2020 $ 43,141 62,814,281 (57,210,888) 5,646,534
Beginning balance, shares at Mar. 31, 2020 43,141,399      
Beginning balance at Dec. 31, 2019 $ 43,069 61,087,082 (52,993,325) 8,136,826
Beginning balance, shares at Dec. 31, 2019 43,069,418      
Equity modification expense       2,290,688
Net loss       (11,557,011)
Ending balance at Sep. 30, 2020 $ 57,963 83,530,601 (64,550,336) 19,038,228
Beginning balance, shares at Sep. 30, 2020 57,963,409      
Beginning balance at Mar. 31, 2020 $ 43,141 62,814,281 (57,210,888) 5,646,534
Beginning balance, shares at Mar. 31, 2020 43,141,399      
Stock based compensation 653,127 653,127
Equity modification expense 998,643 998,643
Sale of common stock in ATM, net $ 2,350 4,302,765 4,305,115
Sale of common stock in ATM, net, shares 2,350,067      
Exercise of employee stock options $ 134 190,197 190,331
Exercise of employee stock options, shares 133,860      
Exercise of warrants $ 20 44,980 45,000
Exercise of warrants, shares 20,000      
Net loss     (4,102,529) (4,102,529)
Ending balance at Jun. 30, 2020 $ 45,645 69,003,993 (61,313,417) 7,736,221
Beginning balance, shares at Jun. 30, 2020 45,645,326      
Stock based compensation 370,685 370,685
Equity modification expense 489,645 489,645
Sale of common stock in ATM, net $ 2,350 4,302,765 4,305,115
Sale of common stock in ATM, net, shares 2,350,067      
Reduction of ATM offering costs   3,237 3,237
Sale of common stock in CMPO, net $ 12,300 13,643,231 13,655,531
Sale of common stock in CMPO, net, shares 12,300,000      
Exercise of employee stock options $ 18 19,810 19,828
Exercise of employee stock options, shares 18,083      
Net loss (3,236,919) (3,236,919)
Ending balance at Sep. 30, 2020 $ 57,963 $ 83,530,601 $ (64,550,336) $ 19,038,228
Beginning balance, shares at Sep. 30, 2020 57,963,409